Skip to main content
OpenTrials

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above

NCT05059301

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Waterbury, Connecticut, United States
  • GSK Investigational Site Brooksville, Florida, United States
  • GSK Investigational Site Immokalee, Florida, United States
  • GSK Investigational Site Buford, Georgia, United States
View all 19 locations
View Trial Details
Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

NCT03814590

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Jacksonville, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Lenexa, Kansas, United States
View all 21 locations
View Trial Details
Completed

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

NCT03636906

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Nampa, Idaho, United States
  • GSK Investigational Site Louisville, Kentucky, United States
  • GSK Investigational Site Baltimore, Maryland, United States
View all 37 locations
View Trial Details
Completed

Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study

NCT04657198

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Elkridge, Maryland, United States
  • GSK Investigational Site Omaha, Nebraska, United States
  • GSK Investigational Site Rochester, New York, United States
View Trial Details
Completed

Ontogeny of Measles Immunity in Infants

NCT00240916

Conditions
Infections, Measles, Mononegavirales Infections, +4 more
Locations
  • Palo Alto Medical Foundation/Department of Pediatrics Palo Alto, California, United States
  • Stanford University School of Medicine Stanford, California, United States
View Trial Details

Related conditions